Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

22 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
The Role of Inflammasomes in Glomerulonephritis.
Anton-Pampols P, Diaz-Requena C, Martinez-Valenzuela L, Gomez-Preciado F, Fulladosa X, Vidal-Alabro A, Torras J, Lloberas N, Draibe J. Anton-Pampols P, et al. Among authors: vidal alabro a. Int J Mol Sci. 2022 Apr 11;23(8):4208. doi: 10.3390/ijms23084208. Int J Mol Sci. 2022. PMID: 35457026 Free PMC article. Review.
PI3K-Akt signaling controls PFKFB3 expression during human T-lymphocyte activation.
Simon-Molas H, Arnedo-Pac C, Fontova P, Vidal-Alabró A, Castaño E, Rodríguez-García A, Navarro-Sabaté À, Lloberas N, Manzano A, Bartrons R. Simon-Molas H, et al. Mol Cell Biochem. 2018 Nov;448(1-2):187-197. doi: 10.1007/s11010-018-3325-9. Epub 2018 Feb 12. Mol Cell Biochem. 2018. PMID: 29435871
Measurement of calcineurin activity in peripheral blood mononuclear cells by ultra-high performance liquid chromatography-tandem mass spectrometry. Renal transplant recipients application (pharmacodynamic monitoring).
Fontova P, Rigo-Bonnin R, Vidal-Alabró A, Cerezo G, Bestard O, Cruzado JM, Torras J, Grinyó JM, Lloberas N. Fontova P, et al. Clin Chim Acta. 2019 Aug;495:287-293. doi: 10.1016/j.cca.2019.04.079. Epub 2019 Apr 27. Clin Chim Acta. 2019. PMID: 31039337
Sustained Inhibition of Calcineurin Activity With a Melt-Dose Once-daily Tacrolimus Formulation in Renal Transplant Recipients.
Fontova P, Colom H, Rigo-Bonnin R, Bestard O, Vidal-Alabró A, van Merendonk LN, Cerezo G, Polo C, Montero N, Melilli E, Manonelles A, Meneghini M, Coloma A, Cruzado JM, Torras J, Grinyó JM, Lloberas N. Fontova P, et al. Among authors: vidal alabro a. Clin Pharmacol Ther. 2021 Jul;110(1):238-247. doi: 10.1002/cpt.2220. Epub 2021 Mar 25. Clin Pharmacol Ther. 2021. PMID: 33626199 Free article. Clinical Trial.
Influence of the Circadian Timing System on Tacrolimus Pharmacokinetics and Pharmacodynamics After Kidney Transplantation.
Fontova P, Colom H, Rigo-Bonnin R, van Merendonk LN, Vidal-Alabró A, Montero N, Melilli E, Meneghini M, Manonelles A, Cruzado JM, Torras J, Grinyó JM, Bestard O, Lloberas N. Fontova P, et al. Among authors: vidal alabro a. Front Pharmacol. 2021 Mar 17;12:636048. doi: 10.3389/fphar.2021.636048. eCollection 2021. Front Pharmacol. 2021. PMID: 33815118 Free PMC article.
Tacrolimus CYP3A Single-Nucleotide Polymorphisms and Preformed T- and B-Cell Alloimmune Memory Improve Current Pretransplant Rejection-Risk Stratification in Kidney Transplantation.
Crespo E, Vidal-Alabró A, Jouve T, Fontova P, Stein M, Mocka S, Meneghini M, Sefrin A, Hruba P, Gomà M, Torija A, Donadeu L, Favà A, Cruzado JM, Melilli E, Moreso F, Viklicky O, Bemelman F, Reinke P, Grinyó J, Lloberas N, Bestard O. Crespo E, et al. Among authors: vidal alabro a. Front Immunol. 2022 Jun 27;13:869554. doi: 10.3389/fimmu.2022.869554. eCollection 2022. Front Immunol. 2022. PMID: 35833145 Free PMC article.
22 results